提醒：Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions 2011年09月02日

来自： Drugs.com - FDA MedWatch Alerts

演示：以MSN订阅提醒为例

哪吒机器人提醒：

提醒：Drugs.com - FDA MedWatch Alerts

【标题】Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions

【摘要】audience: psychiatry, patients [posted 09/01/2011]issue: fda notified healthcare professionals and patients that serious allergic reactions have been reported with the use of saphris (asenapine maleate). the contraindications, warnings and... ... (09-02 09:36)

http://inezha.com/f/72mqvu8d

收藏 | 评论 | 推荐给好友 |

本文共有 0 次分享

来自 Drugs.com - FDA MedWatch Alerts 的其他文章

Reclast (zoledronic acid): Drug Safety Communication - New Contraindication and Updated Warning on Kidney Impairment 2011-09-02 09:36
H & P Industries Povidone Iodine Swabsticks, Prep Solutions, Scrub Solutions, and Prep Gel: Recall - Inadequate Microbial Testing 2011-08-27 08:46
Celexa (citalopram hydrobromide): Drug Safety Communication - Abnormal Heart Rhythms Associated With High Doses 2011-08-25 18:37
Vasopressin Injection USP, Multiple Dose Vials: Recall - Sub-Potency 2011-08-05 08:01
Recombinant Human Growth Hormone (somatropin): Ongoing Safety Review - Possible Increased Risk of Death 2011-08-05 08:01
Diflucan (fluconazole): Drug Safety Communication - Long-term, High-dose Use During Pregnancy May Be Associated With Birth Defects 2011-08-04 07:36
Slim Forte Slimming Capsules, Slim Forte Slimming Coffee, and Botanical Slimming Soft Gel: Public Notification - Undeclared Drug Ingredient 2011-07-28 07:44
CardioGen-82 PET Scan: Drug Safety Communication - Increased Radiation Exposure 2011-07-27 19:17

共有 - 条评论

帐号：对不起，您尚未登录，不能发表评论！登录注册

提醒：Saphris (asenapine maleate): Drug Safety Communication: Serious Allergic Reactions 2011年09月02日

热门点击更多

相关订阅源

最新订阅源